T1	p 387 421	10 patients with asthma due to HDM
T2	i 231 250	local immunotherapy
T3	i 277 318	powder extract of house dust mite ( HDM )
T4	i 340 371	parenteral immunotherapy ( PI )
T5	i 523 530	placebo
T6	i 587 594	lactose
T7	i 676 706	disodium cromoglycate ( DSCG )
T8	o 198 206	efficacy
T9	o 215 227	tolerability
T10	o 756 770	symptoms score
T11	o 778 826	peak expiratory flow ( PEF ) -derived parameters
T12	o 924 942	bronchial response
T13	o 1009 1033	bronchial responsiveness
T14	o 1111 1174	immunologic humoral and cellular parameters in peripheral blood
T15	o 1212 1245	local important adverse reactions
T16	o 1278 1299	systemic side effects
T17	o 1572 1593	systemic side effects